{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:59:24Z","timestamp":1785362364495,"version":"3.55.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L2510101"],"award-info":[{"award-number":["L2510101"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52422316"],"award-info":[{"award-number":["52422316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373124"],"award-info":[{"award-number":["52373124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52403186"],"award-info":[{"award-number":["52403186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52573358"],"award-info":[{"award-number":["52573358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303795"],"award-info":[{"award-number":["82303795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["RDJP2022-69"],"award-info":[{"award-number":["RDJP2022-69"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["BMU2023YFJHPY009"],"award-info":[{"award-number":["BMU2023YFJHPY009"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["2127000305"],"award-info":[{"award-number":["2127000305"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020593","name":"Fundamental Research Funds for the Central Universities of Beijing University of Chemical Technology","doi-asserted-by":"publisher","award":["PT2403"],"award-info":[{"award-number":["PT2403"]}],"id":[{"id":"10.13039\/100020593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015083","name":"Peking University People's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biomaterials.2026.124335","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T15:09:08Z","timestamp":1779548948000},"page":"124335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nanoparticles-mediated dual metabolic-immunological intervention reverses immunosuppression in muscle invasive bladder cancer"],"prefix":"10.1016","volume":"335","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8382-5588","authenticated-orcid":false,"given":"Jiawei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenshan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-3054","authenticated-orcid":false,"given":"Qingsong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biomaterials.2026.124335_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0302-2838(03)00258-6","article-title":"Management and prognosis of transitional cell carcinoma superficial recurrence in muscle-invasive bladder cancer after bladder preservation","volume":"44","author":"Pieras","year":"2003","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124335_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10118-018-2009-y","article-title":"Folic acid modified polymeric micelles for intravesical instilled chemotherapy","volume":"36","author":"Zhou","year":"2018","journal-title":"Chin. J. Polym. Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124335_bib3","article-title":"Small-molecule nanoprodrug with high drug loading and EGFR, PI3K\/AKT dual-inhibiting properties for bladder cancer treatment","volume":"3","author":"Li","year":"2023","journal-title":"Explorations"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124335_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012496","article-title":"MAIT cells promote cancer progression and regulatory T cell accumulation in bladder tumor microenvironment","volume":"13","author":"Habaz","year":"2025","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124335_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221090093","article-title":"Immunotherapeutic significance of a prognostic alternative splicing signature in bladder cancer","volume":"21","author":"Chen","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124335_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/cancers13020288","article-title":"Role of bladder cancer metabolic reprogramming in the effectiveness of immunotherapy","volume":"13","author":"Scholtes","year":"2021","journal-title":"Cancers"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124335_bib7","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1080\/15384101.2015.1053666","article-title":"Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device","volume":"14","author":"Shi","year":"2015","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124335_bib8","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1111\/cas.15047","article-title":"The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets","volume":"112","author":"Burns","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biomaterials.2026.124335_bib9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13046-019-1214-z","article-title":"The roles of glucose metabolic reprogramming in chemo- and radio-resistance","volume":"38","author":"Lin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124335_bib10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.bbrc.2017.11.063","article-title":"FOXJ1 promotes bladder cancer cell growth and regulates Warburg effect","volume":"495","author":"Xian","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biomaterials.2026.124335_bib11","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3389\/fonc.2019.01242","article-title":"MiR-204-3p inhibited the proliferation of bladder cancer cells via modulating lactate dehydrogenase-mediated glycolysis","volume":"9","author":"Guo","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124335_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s13277-014-2617-2","article-title":"A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN\/PI3K\/AKT\/mTOR axis","volume":"36","author":"Yang","year":"2015","journal-title":"Tumor Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124335_bib13","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022110620","article-title":"IDH2 stabilizes HIF-1\u03b1-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer","volume":"42","author":"Shigeta","year":"2023","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124335_bib14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cac2.12158","article-title":"The role of the HIF-1\u03b1\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer","volume":"41","author":"Wang","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.biomaterials.2026.124335_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.174538","article-title":"Arsenic activated GLUT1-mTORC1\/HIF-1\u03b1-PKM2 positive feedback networks promote proliferation and migration of bladder epithelial cells","volume":"947","author":"Fu","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.biomaterials.2026.124335_bib16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jconrel.2022.05.031","article-title":"Bladder cancer selective chemotherapy with potent NQO1 substrate co-loaded prodrug nanoparticles","volume":"347","author":"Jiao","year":"2022","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124335_bib17","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1007\/s13277-013-0909-6","article-title":"Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer","volume":"34","author":"Zhang","year":"2013","journal-title":"Tumor Biol."},{"key":"10.1016\/j.biomaterials.2026.124335_bib18","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.eururo.2025.09.2801","article-title":"SIX1 promotes bladder cancer stemness by repressing DHRS2-mediated lysosomal degradation of CD44","volume":"87","author":"Xie","year":"2025","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124335_bib19","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1007\/s12033-024-01205-7","article-title":"Immunological roles of CCL18 in pan-cancer and its potential value in endometrial cancer","volume":"67","author":"Wang","year":"2025","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124335_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.biocel.2015.06.017","article-title":"Keap1-Nrf2 signalling in pancreatic cancer","volume":"65","author":"Hayes","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124335_bib21","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.7150\/jca.34423","article-title":"p62 suppressed VK3-induced oxidative damage through Keap1\/Nrf2 pathway in human ovarian cancer cells","volume":"11","author":"Xia","year":"2020","journal-title":"J. Cancer"},{"issue":"47","key":"10.1016\/j.biomaterials.2026.124335_bib22","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1038\/onc.2011.646","article-title":"SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation","volume":"31","author":"Ono","year":"2012","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.anl.2020.10.002","article-title":"Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-\u03b2\/Smad2\/3 signaling pathway in papillary thyroid carcinoma","volume":"48","author":"Min","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.biomaterials.2026.124335_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13593","article-title":"NQO1 inhibits proteasome-mediated degradation of HIF-1\u03b1","volume":"7","author":"Oh","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124335_bib25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/jpm12050747","article-title":"Targeting HIF-1\u03b1 function in cancer through the chaperone action of NQO1: implications of genetic diversity of NQO1","volume":"12","author":"Salido","year":"2022","journal-title":"J. Personalized Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124335_bib26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2174\/011574888X265623230921045240","article-title":"Adipose mesenchymal stem cell-derived exosomes enhanced glycolysis through the SIX1\/HBO1 pathway against oxygen and glucose deprivation injury in human umbilical vein endothelial cells","volume":"19","author":"Zhang","year":"2024","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124335_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1517\/14712590902849216","article-title":"Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy","volume":"9","author":"Steenblock","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124335_bib28","article-title":"Highly biocompatible functionalized layer-by-layer ginger lipid nano vectors targeting P-selectin for delivery of doxorubicin to treat Colon cancer","volume":"2","author":"Zhang","year":"2019","journal-title":"Adv. Ther."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124335_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1208\/s12249-019-1367-2","article-title":"Translational multi-disciplinary approach for the drug and gene delivery systems for cancer treatment","volume":"20","author":"Nayak","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124335_bib30","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10118-023-2958-7","article-title":"Paclitaxel prodrug nanomedicine for potential CT-imaging guided breast cancer therapy","volume":"41","author":"Chen","year":"2023","journal-title":"Chin. J. Polym. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124335_bib31","article-title":"Stimuli-responsive crosslinked nanomedicine for cancer treatment","volume":"2","author":"Xue","year":"2022","journal-title":"Explorations"},{"key":"10.1016\/j.biomaterials.2026.124335_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2019.02.003","article-title":"Rationally designed DNA-based nanocarriers","volume":"147","author":"Jiang","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"27","key":"10.1016\/j.biomaterials.2026.124335_bib33","doi-asserted-by":"crossref","first-page":"24377","DOI":"10.1021\/acsami.9b04142","article-title":"Gated mesoporous silica nanocarriers for hypoxia-responsive cargo release","volume":"11","author":"Yan","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124335_bib34","doi-asserted-by":"crossref","first-page":"15986","DOI":"10.1021\/acsami.7b03317","article-title":"Bioreducible polymer nanocarrier based on multivalent choline phosphate for enhanced cellular uptake and intracellular delivery of doxorubicin","volume":"9","author":"Wang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124335_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/iub.70071","article-title":"Next-generation nanomaterials in biology: from tissue regeneration to targeted cancer therapy","volume":"77","author":"Barik","year":"2025","journal-title":"IUBMB Life"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124335_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202200289","article-title":"Macrophage cell membrane-cloaked nanoplatforms for biomedical applications","volume":"6","author":"Lopes","year":"2022","journal-title":"Small Methods"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124335_bib37","article-title":"Dynamic regulation of drug biodistribution by turning tumors into decoys for biomimetic nanoplatform to enhance the chemotherapeutic efficacy of breast cancer with bone metastasis","volume":"3","author":"Zheng","year":"2023","journal-title":"Explorations"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib38","article-title":"Harnessing anti-tumor and tumor-tropism functions of macrophages via nanotechnology for tumor immunotherapy","volume":"2","author":"Zheng","year":"2022","journal-title":"Explorations"},{"key":"10.1016\/j.biomaterials.2026.124335_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2023.102663","article-title":"Macrophage cell membrane infused biomimetic liposomes for glioblastoma targeted therapy","volume":"49","author":"Mendanha","year":"2023","journal-title":"Nanomed. Nanotechnol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302238","article-title":"Biomimetic nanocarriers of pro-resolving lipid mediators for resolution of inflammation in atherosclerosis","volume":"13","author":"Anghelache","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124335_bib41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40005-025-00754-6","article-title":"Engineered macrophages as versatile platforms for targeted cancer immunotherapy","volume":"55","author":"Mujahid","year":"2025","journal-title":"J. Pharm. Investig."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib42","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1021\/acsomega.9b03531","article-title":"Transmembrane TNF\u03b1-Expressed macrophage membrane-coated chitosan nanoparticles as cancer therapeutics","volume":"5","author":"Bhattacharyya","year":"2020","journal-title":"ACS Omega"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124335_bib43","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.apsb.2023.03.004","article-title":"Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis","volume":"13","author":"Zhu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124335_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11095-018-2477-3","article-title":"Drug-polymer interaction, pharmacokinetics and antitumor effect of PEG-PLA\/Taxane derivative TM-2 micelles for intravenous drug delivery","volume":"35","author":"Wang","year":"2018","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124335_bib45","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2177362","article-title":"Arenobufagin-loaded PEG-PLA nanoparticles for reducing toxicity and enhancing cancer therapy","volume":"30","author":"Jiaying","year":"2023","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124335_bib46","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1021\/acs.biomac.8b00130","article-title":"Lipoyl ester terminated star PLGA as a simple and smart material for controlled drug delivery application","volume":"19","author":"Wang","year":"2018","journal-title":"Biomacromolecules"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124335_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108135","article-title":"PDLLA length on anti-breast cancer efficacy of acid-responsive self-assembling mPEG-PDLLA\u2012docetaxel conjugates","volume":"34","author":"Liu","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.biomaterials.2026.124335_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.12.026","article-title":"Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles","volume":"201","author":"Colombo","year":"2015","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124335_bib49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2011.08.011","article-title":"Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA","volume":"157","author":"Jensen","year":"2012","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124335_bib50","article-title":"Exploring precision treatments in immune-mediated inflammatory diseases: harnessing the infinite potential of nucleic acid delivery","volume":"5","author":"Xu","year":"2025","journal-title":"Explorations"},{"key":"10.1016\/j.biomaterials.2026.124335_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123994","article-title":"Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells","volume":"654","author":"Rinaldi","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124335_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cbi.2006.01.005","article-title":"PS exposure increases the susceptibility of cells to fusion with DOTAP liposomes","volume":"160","author":"Stebelska","year":"2006","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124335_bib53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/adhm.201300503","article-title":"Effective nanoparticle-based gene delivery by a protease triggered charge switch","volume":"3","author":"Gjetting","year":"2014","journal-title":"Adv. Healthcare Mater."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124335_bib54","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3390\/membranes13110871","article-title":"Membrane-mediated cooperative interactions of CD47 and SIRP\u03b1","volume":"13","author":"Li","year":"2023","journal-title":"Membranes"},{"issue":"47","key":"10.1016\/j.biomaterials.2026.124335_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004853","article-title":"Activating macrophage-mediated cancer immunotherapy by genetically edited nanoparticles","volume":"32","author":"Rao","year":"2020","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/ejcrp.eJCRP-D-23-00006","article-title":"Anti-CD47 antibodies: a potential new cancer immunotherapy","volume":"10","author":"Jian","year":"2023","journal-title":"J. Cancer Res. Pract."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124335_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404782","article-title":"Biomimetic membrane vesicles reprogram microglia polarization and remodel the immunosuppressive microenvironment of glioblastoma via PERK\/HIF-1\u03b1\/Glycolysis pathway","volume":"14","author":"Guo","year":"2025","journal-title":"Adv. Healthcare Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124335_bib58","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.pathol.2023.05.003","article-title":"Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours","volume":"55","author":"Zuba\u013e","year":"2023","journal-title":"Pathology"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124335_bib59","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1600-0501.2007.01373.x","article-title":"Adsorption of human plasma proteins to modified titanium surfaces","volume":"18","author":"Sela","year":"2007","journal-title":"Clin. Oral Implants Res."},{"key":"10.1016\/j.biomaterials.2026.124335_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123299","article-title":"Improved biocompatibility of dendrimer-based gene delivery by histidine-modified nuclear localization signals","volume":"644","author":"Lee","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124335_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202009768","article-title":"Photocrosslinked bioreducible polymeric nanoparticles for enhanced systemic siRNA delivery as cancer therapy","volume":"31","author":"Karlsson","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124335_bib62","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cej.2025.162865","article-title":"Macrophage-camouflaged nano-gasholder mediates a differentiated delivery of nitric oxide for blocking cancer-bone crosstalk and bone metastases","volume":"513","author":"Zhang","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124335_bib63","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1021\/acsami.8b13059","article-title":"PEG-detachable polymeric micelles self-assembled from amphiphilic copolymers for tumor-acidity-triggered drug delivery and controlled release","volume":"11","author":"Xu","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124335_bib64","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3390\/ijms21051856","article-title":"Cell-penetrating peptide modified PEG-PLA micelles for efficient PTX delivery","volume":"21","author":"Shuai","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124335_bib65","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2011.02.027","article-title":"Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)\u2013poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis","volume":"151","author":"Liu","year":"2011","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124335_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155945","article-title":"Saikosaponin D potentiates the antineoplastic effects of doxorubicin in drug-resistant breast cancer through perturbing NQO1-mediated intracellular redox balance","volume":"133","author":"Luo","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biomaterials.2026.124335_bib67","first-page":"490","article-title":"ROS-responsive and triple-synergistic mitochondria-targeted polymer micelles for efficient induction of ICD in tumor therapeutics","volume":"36","author":"Hu","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2026.124335_bib68","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.2147\/IJN.S333197","article-title":"Immunogenic cell death induced by chemoradiotherapy of novel pH-Sensitive cargo-loaded polymersomes in glioblastoma","volume":"16","author":"He","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2026.124335_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100977","article-title":"Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis","volume":"70","author":"Yu","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124335_sref70","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib70a","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s13277-013-1258-1","article-title":"Inhibition of Six1 promotes apoptosis, suppresses proliferation, and migration of osteosarcoma cells","volume":"35","author":"Hua","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.biomaterials.2026.124335_bib71","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.biopha.2016.10.028","article-title":"Pro-survival effects by NF-\u03baB, Akt and ERK(1\/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4\/5 pathway in ovarian cancer","volume":"84","author":"Yang","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib72","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","article-title":"HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption","volume":"3","author":"Papandreou","year":"2006","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib73","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s12013-025-01714-5","article-title":"sPLA2-IB and PLA2R mediate aberrant glucose metabolism in podocytes via hyperactivation of the mTOR\/HIF-1\u03b1 pathway","volume":"83","author":"Bao","year":"2025","journal-title":"Cell Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13577-025-01215-w","article-title":"SIX1 enhances aerobic glycolysis and progression in cervical cancer through ENO1","volume":"38","author":"Liu","year":"2025","journal-title":"Hum. Cell"},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124335_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810704","article-title":"An axis between the long non-coding RNA HOXA11-AS and NQOs enhances metastatic ability in oral squamous cell carcinoma","volume":"23","author":"Nakashima","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124335_bib76","article-title":"The SIX1\/LDHA axis promotes lactate accumulation and leads to NK cell dysfunction in pancreatic cancer","volume":"2023","author":"Ge","year":"2023","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib77","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","article-title":"Environment impacts the metabolic dependencies of ras-driven non-small cell lung cancer","volume":"23","author":"Davidson","year":"2016","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124335_bib78","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1172\/JCI27745","article-title":"CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells","volume":"116","author":"Quezada","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124335_bib79","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.21037\/tcr-24-1053","article-title":"Comprehensive analysis of tumor immune-related gene signature for predicting prognosis, immunotherapy, and drug sensitivity in bladder urothelial carcinoma","volume":"13","author":"Guo","year":"2024","journal-title":"Transl. Cancer Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124335_bib80","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.urolonc.2017.01.014","article-title":"Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: a retrospective study","volume":"35","author":"Le Goux","year":"2017","journal-title":"Urol. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124335_bib81","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2018.08.027","article-title":"Molecular subtypes of urothelial bladder cancer: results from a meta-cohort analysis of 2411 tumors","volume":"75","author":"Tan","year":"2019","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124335_bib82","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41591-026-04271-3","article-title":"Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial","volume":"32","author":"Mellema","year":"2026","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124335_bib83","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1158\/1078-0432.CCR-25-3771","article-title":"Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder","volume":"32","author":"Guercio","year":"2026","journal-title":"Cancer. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124335_bib84","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1172\/JCI27745","article-title":"CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells","volume":"116","author":"Quezada","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124335_bib85","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1464-410X.1987.tb09134.x","article-title":"Instillation of mitomycin C and doxorubicin in the prevention of recurrent superficial (Ta-T1) bladder cancer","volume":"60","author":"Jauhiainen","year":"1987","journal-title":"Br. J. Urol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124335_bib86","first-page":"572","article-title":"Intravesical liposome drug delivery and IC\/BPS","volume":"4","author":"Janicki","year":"2015","journal-title":"Transl. Androl. Urol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226003595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226003595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:24:07Z","timestamp":1785360247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226003595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":87,"alternative-id":["S0142961226003595"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124335","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticles-mediated dual metabolic-immunological intervention reverses immunosuppression in muscle invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124335"}}